Supportive Care in Older Adults with Cancer: Across the Continuum
- 531 Downloads
Supportive care is an essential component of anticancer treatment regardless of age or treatment intent. As the number of older adults with cancer increases, and supportive care strategies enable more patients to undergo treatment, greater numbers of older patients will become cancer survivors. These patients may have lingering adverse effects from treatment and will need continued supportive care interventions. Older adults with cancer benefit from geriatric assessment (GA)-guided supportive care interventions. This can occur at any stage across the cancer treatment continuum. As a GA commonly uncovers issues potentially unrelated to anticancer treatment, it could be argued that the assessment is essentially a supportive care strategy. Key aspects of a GA include identification of comorbidities, assessing for polypharmacy, screening for cognitive impairment and delirium, assessing functional status, and screening for psychosocial issues. Treatment-related issues of particular importance in older adults include recognition of increased bone marrow toxicity, management of nausea and vomiting, identification of anemia, and prevention of neurotoxicity. The role of physical therapy and cancer rehabilitation as a supportive care strategy in older adults is important regardless of treatment stage or intent.
KeywordsSupportive care Geriatric oncology Older adults Cancer Geriatric assessment-guided intervention Survivorship
Compliance with Ethical Standard
Conflict of Interest
Thuy Koll, Mackenzi Pergolotti, Holly M. Holmes, Huibrie C. Pieters, GJ van Londen, Zachary A. Marcum, Amy R. MacKenzie, and Christopher B. Steer declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.National Cancer Institute. Dictionary of cancer terms—supportive care. http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46609. Accessed 5/3/2016.
- 2.Multinational association for supportive care in cancer. What is MASCC? http://www.mascc.org/about-mascc. Accessed 05/03/2016.
- 5.National Coalition for Cancer Survivorship. Defining cancer survivorship 2014. http://www.canceradvocacy.org/news/defining-cancer-survivorship/. Accessed 5/3/2016.
- 6.National Cancer Institute. Dictionary of cancer terms—survivor. http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=450125. Accessed 5/3/2016 2016.
- 7.Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. Journal of Clinical Oncology. 2014:JCO. 2013.54. 8347.Google Scholar
- 9.•Mohile SG, Velarde C, Hurria A, Magnuson A, Lowenstein L, Pandya C, et al. Geriatric assessment-guided care processes for older adults: a Delphi consensus of geriatric oncology experts. J Natl Compr Canc Netw. 2015;13(9):1120–30. In the absence of randomised trial evidence of the utility of geriatric assessment in older adults with cancer this Delphi consensus of expert opinion provides a framework for GA-guided supportive care interventions in this patient population.PubMedGoogle Scholar
- 12.National Comprehensive Cancer Network (NCCN). Older adult oncology. 2016. http://www.nccn.org/professionals/physician_gls/pdf/senior.pdf. Accessed 14/2/2016.
- 14.Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, et al. Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol. 2008;26(8):1231–8. doi: 10.1200/JCO.2007.13.5467.PubMedPubMedCentralCrossRefGoogle Scholar
- 15.Gewandter JS, Fan L, Magnuson A, Mustian K, Peppone L, Heckler C, et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013;21(7):2059–66. doi: 10.1007/s00520-013-1766-y.PubMedPubMedCentralCrossRefGoogle Scholar
- 21.Nightingale G, Hajjar E, Guo K, Komura S, Urnoski E, Sendecki J, et al. A pharmacist-led medication assessment used to determine a more precise estimation of the prevalence of complementary and alternative medication (CAM) use among ambulatory senior adults with cancer. J Geriatr Oncol. 2015. doi: 10.1016/j.jgo.2015.07.003.PubMedGoogle Scholar
- 22.Maggiore RJ, Dale W, Gross CP, Feng T, Tew WP, Mohile SG, et al. Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment. J Am Geriatr Soc. 2014;62(8):1505–12. doi: 10.1111/jgs.12942.PubMedPubMedCentralCrossRefGoogle Scholar
- 23.••Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015;33(13):1453–9. doi: 10.1200/JCO.2014.58.7550. A key study documenting the important role of the pharmacist in a senior adult oncology clinic.PubMedCrossRefGoogle Scholar
- 24.Prithviraj GK, Koroukian S, Margevicius S, Berger NA, Bagai R, Owusu C. Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012;3(3):228–37. doi: 10.1016/j.jgo.2012.02.005.PubMedPubMedCentralCrossRefGoogle Scholar
- 31.Lilamand M, Kelaiditi E, Cesari M, Raynaud-Simon A, Ghisolfi A, Guyonnet S, et al. Validation of the Mini Nutritional Assessment-Short Form in a population of frail elders without disability. Analysis of the Toulouse Frailty Platform Population in 2013. J Nutr Health Aging. 2015;19(5):570–4. doi: 10.1007/s12603-015-0457-4.PubMedCrossRefGoogle Scholar
- 37.NIH Consensus Development Panel on Depression in Late Life. Diagnosis and treatment of depression in late life. JAMA. 1992;168:1018–24.Google Scholar
- 46.Audisio RA, Pope D, Ramesh HS, Gennari R, van Leeuwen BL, West C, et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008;65(2):156–63. doi: 10.1016/j.critrevonc.2007.11.001.PubMedCrossRefGoogle Scholar
- 49.Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–94.PubMedCrossRefGoogle Scholar
- 54.Versteeg KS, Konings IR, Lagaay AM, van de Loosdrecht AA, Verheul HM. Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review. Ann Oncol. 2014;25(10):1914–8. doi: 10.1093/annonc/mdu052.PubMedCrossRefGoogle Scholar
- 55.Wang L, Baser O, Kutikova L, Page JH, Barron R. The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials. Support Care Cancer. 2015;23(11):3131–40. doi: 10.1007/s00520-015-2686-9.PubMedPubMedCentralCrossRefGoogle Scholar
- 57.National Comprehensive Cancer Network (NCCN). Myeloid growth factors. In: NCCN Guidelines. 2015. http://www.nccn.org/professionals/physician_gls/pdf/myeloid_growth.pdf. Accessed 14/2/2016.
- 59.Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 2011;47(1):8–32. doi: 10.1016/j.ejca.2010.10.013.PubMedCrossRefGoogle Scholar
- 60.Morrison VA, Hamlin P, Soubeyran P, Stauder R, Wadhwa P, Aapro M, et al. Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary. Ann Oncol. 2015;26(6):1058–68. doi: 10.1093/annonc/mdv018.PubMedCrossRefGoogle Scholar
- 61.•Elting LS, Xu Y, Chavez-MacGregor M, Giordano SH. Granulocyte growth factor use in elderly patients with non-Hodgkin’s lymphoma in the United States: adherence to guidelines and comparative effectiveness. Support Care Cancer. 2016. doi: 10.1007/s00520-016-3079-4. This population-based study shows that GCSF use in adults over the age of 65 years receiving chemotherapy for NHL decreased outpatient encounters for fever or infection, but not inpatient encounters or deaths during cycle 1.
- 65.National Comprehensive Cancer Network (NCCN). Cancer- and chemotherapy-induced anemia. In: NCCN Guidelines. 2016. http://www.nccn.org/professionals/physician_gls/pdf/anemia.pdf. Accessed 14/2/2016.
- 66.Gafter-Gvili A, Rozen-Zvi B, Vidal L, Leibovici L, Vansteenkiste J, Gafter U, et al. Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia—systematic review and meta-analysis of randomised controlled trials. Acta Oncol. 2013;52(1):18–29. doi: 10.3109/0284186X.2012.702921.PubMedCrossRefGoogle Scholar
- 67.Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N, et al. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J Pain Symptom Manage. 2014;47(5):839–48. doi: 10.1016/j.jpainsymman.2013.06.012. e4.PubMedCrossRefGoogle Scholar
- 69.Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol. 2010;21 Suppl 5:v232–43. doi: 10.1093/annonc/mdq194.PubMedCrossRefGoogle Scholar
- 73.Lichtman SM, Wildiers H, Chatelut E, Steer C, Budman D, Morrison VA, et al. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients—an analysis of the medical literature. J Clin Oncol. 2007;25(14):1832–43. doi: 10.1200/JCO.2007.10.6583.PubMedCrossRefGoogle Scholar
- 74.Kurtz JE, Kaminsky MC, Floquet A, Veillard AS, Kimmig R, Dorum A, et al. Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study. Ann Oncol. 2011;22(11):2417–23. doi: 10.1093/annonc/mdr001.PubMedCrossRefGoogle Scholar
- 75.Tew W, Java J, Chi D, Menzin A, Lovecchio J, Bookman M et al., editors. Treatment outcomes for older women with advanced ovarian cancer: results from a phase III clinical trial (GOG182). J Clin Oncol (ASCO Meeting Abstracts); 2010.Google Scholar
- 84.•Pergolotti M, Deal AM, Lavery J, Reeve BB, Muss HB. The prevalence of potentially modifiable functional deficits and the subsequent use of occupational and physical therapy by older adults with cancer. J Geriatr Oncol. 2015. doi: 10.1016/j.jgo.2015.01.004. This study showed that potentially modifiable functional deficits are common in older adults with cancer but rehabilitation and physical therapy services are underutilized in this population.PubMedPubMedCentralGoogle Scholar
- 86.Association AOT. About occupational therapy. 2016. http://www.aota.org/about-occupational-therapy.aspx. Accessed February, 18 2016 2016.
- 92.Association APT. Who are phyiscal therapists? 2016. http://www.apta.org/AboutPTs/. Accessed February 18th, 2016
- 94.Deyle GD, Allison SC, Matekel RL, Ryder MG, Stang JM, Gohdes DD, et al. Physical therapy treatment effectiveness for osteoarthritis of the knee: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise program. Phys Ther. 2005;85(12):1301–17.PubMedGoogle Scholar
- 97.Morano MT, Araújo AS, Nascimento FB, da Silva GF, Mesquita R, Pinto JS, et al. Preoperative pulmonary rehabilitation versus chest physical therapy in patients undergoing lung cancer resection: a pilot randomized controlled trial. Arch Phys Med Rehabil. 2013;94(1):53–8. doi: 10.1016/j.apmr.2012.08.206.PubMedCrossRefGoogle Scholar
- 102.Zlatiev-Scocard N. Bereavement follow-up: a preventative programme. In: Michel J-P, HofPR, ed. Management of ageing. Basel: Karger, 1999: 199–207Google Scholar